REGENXBIO INC. DL-,0001 WKN: A140E0 ISIN: US75901B1070 Kürzel: RB0 Forum: Aktien Thema: Hauptdiskussion
8,36 USD
+2,08 %+0,17
7. Jan, 23:20:00 Uhr,
Nasdaq
Kommentare 88
Billi1,
18. Okt 19:59 Uhr
0
👀
Summer.76,
02.08.2024 3:36 Uhr
0
https://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-new-positive-data-affinity-duchenner-trial
Summer.76,
02.08.2024 3:36 Uhr
0
https://ir.regenxbio.com/news-releases/news-release-details/regenxbio-reports-second-quarter-2024-financial-results-and
Summer.76,
07.03.2024 8:12 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-announces-pricing-of-upsized-public-offering-of-common-stock-and-pre-funded-warrants-302082361.html
Summer.76,
05.03.2024 13:44 Uhr
0
🍀
Summer.76,
05.03.2024 13:43 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-announces-new-positive-initial-efficacy-data-from-affinity-duchenne-trial-302079525.html
Summer.76,
27.02.2024 22:09 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-reports-fourth-quarter-and-full-year-2023-financial
Summer.76,
07.02.2024 19:01 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-announces-pivotal-trial-rgx-121-treatment-mps-ii
Summer.76,
07.02.2024 19:01 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-announces-completion-enrollment-cohort-2-and
Summer.76,
04.10.2023 5:15 Uhr
0
REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNE™ Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society
https://www.prnewswire.com/news-releases/regenxbio-presents-interim-clinical-data-from-phase-iii-affinity-duchenne-trial-of-rgx-202-at-28th-annual-international-congress-of-the-world-muscle-society-301946289.html
Summer.76,
02.08.2023 22:07 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-reports-second-quarter-2023-financial-results-and-recent-operational-highlights-301891935.html
Summer.76,
03.05.2023 22:10 Uhr
0
https://regenxbio.gcs-web.com/news-releases/news-release-details/regenxbio-reports-first-quarter-2023-financial-results-and
Summer.76,
11.04.2023 15:10 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-receives-fda-fast-track-designation-for-rgx-202-a-novel-gene-therapy-candidate-for-the-treatment-of-duchenne-muscular-dystrophy-301794029.html
Solix,
11.04.2023 13:07 Uhr
0
🎈
Summer.76,
28.02.2023 22:07 Uhr
0
https://www.prnewswire.com/news-releases/regenxbio-reports-fourth-quarter-2022-and-full-year-2022-financial-results-and-recent-operational-highlights-301758593.html
Summer.76,
22.02.2023 22:41 Uhr
0
https://www.prnewswire.com/news-releases/additional-positive-interim-data-from-phase-iiiiii-campsiite-trial-of-regenxbios-rgx-121-for-the-treatment-of-mps-ii-hunter-syndrome-presented-at-19th-annual-worldsymposiumtm-301753564.html
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | ATOS Hauptdiskussion | -14,29 % | |
| 2 | Realbotix neuer 10 Bagger? | -20,13 % | |
| 3 | Plug Power ohne Spam | -9,84 % | |
| 4 | PLUG POWER Hauptdiskussion | -9,84 % | |
| 5 | Carl Infiniti ai | +51,80 % | |
| 6 | Austausch Toggle3D | +110,66 % | |
| 7 | NVIDIA Hauptdiskussion | -5,45 % | |
| 8 | Security der nächsten Generation | -13,93 % | |
| 9 | DPCM Capital Hauptdiskussion | -14,85 % | |
| 10 | Vulcan Energy Resources Hauptdiskussion | ±0,00 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | ATOS Hauptdiskussion | -14,29 % | |
| 2 | Realbotix neuer 10 Bagger? | -20,13 % | |
| 3 | Plug Power ohne Spam | -9,84 % | |
| 4 | PLUG POWER Hauptdiskussion | -9,84 % | |
| 5 | Carl Infiniti ai | +51,80 % | |
| 6 | Austausch Toggle3D | +110,66 % | |
| 7 | NVIDIA Hauptdiskussion | -5,45 % | |
| 8 | Security der nächsten Generation | -13,93 % | |
| 9 | Vulcan Energy Resources Hauptdiskussion | ±0,00 % | |
| 10 | DPCM Capital Hauptdiskussion | -14,85 % | Alle Diskussionen |